Advertisement
News
Subscribe to MDT Magazine News

Giant Eagle® Expands Free Prescription Program to Include Free Diabetes Medicines in Northeast Ohio

July 29, 2010 9:34 am | by Bio-Medicine.Org | Comments

CLEVELAND , July 29 /- With diabetes affecting the lives of hundreds of thousands of people throughout Ohio and Pennsylvania , Giant Eagle®, Inc. has announced that it will begin offering five commonly prescribed medications for the treatment of type 2 diabetes at no cost to medical...

TOPICS:

Giant Eagle® Expands Free Prescription Program To Include Free Diabetes Medicines in Western Pennsylvania

July 29, 2010 9:34 am | by Bio-Medicine.Org | Comments

PITTSBURGH , July 29 /- With diabetes affecting the lives of hundreds of thousands of people throughout Pennsylvania and Ohio , Giant Eagle®, Inc. has announced that it will begin offering five commonly prescribed medications for the treatment of type 2 diabetes at no cost to medical...

TOPICS:

NCPA Statement on CVS Caremark-Aetna Agreement

July 29, 2010 9:34 am | by Bio-Medicine.Org | Comments

ALEXANDRIA, Va. , July 29 /PRNewswire-USNewswire/ -- In response to the agreement announced that CVS Caremark would provide pharmacy benefits to all 9.7 million lives covered by insurance giant Aetna, the National Community Pharmacists Association (NCPA) issued the following statement...

TOPICS:
Advertisement

Walter H.C. Drakeford Named Co-President and Co-Chairman of the Board of Directors for MIT Holding, Inc.

July 29, 2010 9:34 am | by Bio-Medicine.Org | Comments

SAVANNAH, Ga. , July 29 /- MIT Holding, Inc. announces that Walter H.C. Drakeford has been named co-president and co-chairman of the board of directors. MIT Holding, Inc. founder William "Rocky" Parker will also serve as co-president and co-chairman of the board of directors. Drakeford's...

TOPICS:

Analysis Finds U.S. Medical-Surgical Manufacturers Using GHX Market Intelligence Grew Revenue Faster Than Non-Users in 2009

July 29, 2010 9:34 am | by Bio-Medicine.Org | Comments

LOUISVILLE, Colo. , July 29 /- An analysis of medical-surgical sales through distribution conducted by GHX has found that among the top 100 U.S. medical-surgical manufacturers by dollar spend, those that use GHX Market Intelligence data grew medical-surgical revenue through distribution...

TOPICS:

Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010

July 29, 2010 9:34 am | by Bio-Medicine.Org | Comments

AUSTIN, Texas ,  July 29 /- Vermillion, Inc. (Nasdaq: VRML ), a molecular diagnostics company, will host a web cast and conference call to give a company update following issuance of Q2 financial results on Monday, August 16, 2010 . Conference Call Information To access the live...

TOPICS:

Magellan Health 2Q profit rises 90 percent

July 29, 2010 8:45 am | by The Associated Press | Comments

Magellan Health Services Inc. said Thursday that its second-quarter profit nearly doubled, and the health care outsourcing company raised its profit estimate for the year.Magellan's profit jumped 90 percent to $35.1 million, or $1.05 per share, from $18.5 million, or 53 cents per share, in the...

Dentsply International 2Q profit rises 3 percent

July 29, 2010 8:45 am | by The Associated Press | Comments

Dental products maker Dentsply International Inc. said Thursday its second-quarter profit rose 3 percent as an improved global economy boosted its sales.Dentsply said it earned $72.4 million, or 49 cents per share, over the three months that ended June 30. That's up from $70.2 million, or 47...

Advertisement

Covidien reports bumps in sales and profit

July 29, 2010 8:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Medical device manufacturer Covidien plc has reported its third quarter results, including a 2 percent increase in net sales and net income of $364 million, compared with $281 million in the same quarter in 2009.

TOPICS:

Suresh named chair of anesthesiology at Baylor College of Medicine

July 29, 2010 8:34 am | by Baylor College of Medicine | Comments

Dr. Maya S. Suresh was named chair of the Department of Anesthesiology at Baylor College of Medicine by the college's board of trustees Wednesday. "Dr. Suresh has a clear vision for the future of this important discipline at Baylor College of Medicine," said Dr. Stephen Spann, senior vice...

TOPICS:

Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia

July 29, 2010 8:30 am | by U.S. Food & Drug Administration | Comments

Cases of serious, potentially fatal pneumonia associated with the IV antibacterial drug Cubicin.

TOPICS:

Report: Sanofi may make $18.7B bid for Genzyme

July 29, 2010 6:36 am | by Mass High Tech: The Journal of New England Technology | Comments

French drug maker Sanofi-Aventis plans to make a formal bid to buy Genzyme Corp., for as much as $18.7 billion, Reuters news agency is reporting, quoting unnamed sources.

Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia

July 29, 2010 6:35 am | by Bio-Medicine.Org | Comments

NEW YORK , July 29 /- Intra-Cellular Therapies, Inc. today announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, investigational new drug for the treatment of schizophrenia.  The trial met its primary endpoint...

TOPICS:

Shionogi Inc. Announces FDA Approval of CUVPOSAâ„¢ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions

July 29, 2010 6:35 am | by Bio-Medicine.Org | Comments

FLORHAM PARK, N.J. , July 29 /- Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), the first liquid treatment for patients ages 3-16 who suffer from chronic severe...

TOPICS:

Marina Biotech, Inc. Announces Upcoming Investor Conference Presentations

July 29, 2010 5:45 am | by The Associated Press | Comments

Marina Biotech, Inc. (NASDAQ: MRNAD), formerly known as MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced that J. Michael French, Marina's President and Chief Executive Officer, will provide an overview of the Company and its progress in key...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading